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80 kDa diacylglycerol kinase (DGK) was immunoquantitated in cell homogenates and subcellular fractions. It was ex- 
tremely abundant in the cytosol of various lymphocytes and comprised, in the highest case, more than 0.2% of the total 
soluble protein in T cell-enriched pig splenocytes. The lymphocyte membrane contained less than 10% of the total cellular 
DGK protein. The content of 80 kDa DGK in the human T cell leukemic cell line, Jurkat (360 ng/mg homogenate pro- 
tein), was similar to those in pig and human peripheral blood lymphocytes. In contrast, the enzyme level was very low 
in the human promyeloblastic cell line, HL-60 (< 10 ng/mg homogenate protein), and was undetectable in human poly- 
morphonuclear leukocytes. These findings indicate that the content of 80 kDa DGK is markedly variable depending on 
the type of cells, even though all these cells are known to accumulate phosphatidate rapidly upon cell stimulation. 
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I. INTRODUCTION 
Diacylglycerol kinase (DGK) is responsible for 
rapid accumulation of phosphatidate in agonist- 
stimulated cells [I ,2]. It also plays an important 
role in metabolic control by initiating the resyn- 
thesis of phosphatidylinositols and regulating the 
level of diacylglycerol, a second messenger [3-51. 
Phosphatidate and diacylglycerol are also precur- 
sors of the other phospholipids. Since DGK per- 
forms such important functions, it is conceivable 
that its activity is strictly controlled in stimulated 
and normal cells. The only DGK so far purified 
from animal sources is that from pig brain that has 
an apparent molecular mass of 80 kDa [6-81. 
However, we have recently shown that pig tissues 
contain at least two other DGK isozymes that are 
immunologically distinct from the 80 kDa enzyme 
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[9]. Moreover, it has also been shown that 80 kDa 
DGK occurs only in brain and lymphoid tissues 
and is almost absent in cells such as platelets and 
hepatocytes [9]. The multiplicity of DGK has also 
been reported in Swiss 3T3 cells [lo, 111. The 
possibility therefore arises that different DGK 
isozymes function in different cell types under dif- 
ferent control mechanisms. To elucidate the 
physiological significance of DGK, therefore, it is 
desirable to quantitate each DGK isozyme in dif- 
ferent types of cells. 
Here, we report the quantitation of 80 kDa 
DGK in human and pig lymphocytes and several 
other cells. For this purpose, we used immuno- 
quantitation for two reasons. Firstly, only the 
80 kDa isozyme can be measured by this method. 
Secondly, by using this procedure, it is possible to 
avoid difficulties associated with DGK activity 
assays. The difficulties have been discussed in 
detail for E. coli DGK [ 12,131. Although the mixed 
micellar method has been developed for the 
bacterial enzyme [ 12,131 and recently applied to 
the fibroblast enzyme [lO,ll], we have found that 
octylglucoside used in this method strongly in- 
hibited purified 80 kDa DGK (unpublished). Fur- 
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thermore, the occurrence of an endogenous (10-250 pg protein) were analyzed on the same gel to quantify 
inhibitor in rat brain has been reported [14]. the enzyme. 
2.6. Other methods 
2. MATERIALS AND METHODS 
2.1. Anti-80 kDa DGK antibody and human cell lines 
The preparation and characterization of rabbit antibody to 
pig brain 80 kDa DGK have been described [8,9]. The human 
T cell leukemic ell line, Jurkat, and the human promyeloblastic 
cell line, HL-60, were donated by Dr T. Uede of Sapporo 
Medical College. The cells were cultivated under 5% CO2/95% 
air in RPM1 1640 medium (Nissui, Japan) supplemented with 
10% heat-inactivated fetal bovine serum (Gibco, USA). 
Immunoprecipitation of soluble DGK [9], assay of DGK ac- 
tivity [6] and protein determination [17] were carried out as 
described. Bovine serum albumin was used as a standard for 
protein determination. 
3. RESULTS AND DISCUSSION 
2.2. Isolation of cells 
Pig splenocytes and thymocytes were isolated, after 
hypotonic hemolysis if necessary, by lymphocyte M (Cedarlane, 
Canada) gradient centrifugation as in [15]. Splenocyte were 
fractionated into T cell- and B cell-enriched populations by a 
nylon fiber column [IS]. Peripheral blood lymphocytes (PBL) 
and polymorphonuclear leucocytes (PMN) were isolated from 
fresh human blood by dextran sedimentation, hypotonic 
hemolysis, and Ficoll-Hypaque (Pharmacia, Sweden) cen- 
trifugation [15]. 
2.3. Cell homogenization and fractionation 
Cells to be examined were suspended in 25 mM Tris-HCI buf- 
fer (pH 7.4) containing 0.25 M sucrose, 2 mM EDTA, 0.5 mM 
DTT, 10pM ATP, and 1 mM phenylmethylsulfonyl fluoride. 
The suspension was briefly sonicated at 0°C and centrifuged at 
200 x g for 5 min to remove cell debris, and the resultant super- 
natant was used as cell homogenate. The homogenate was frac- 
tionated into the cytosolic and membrane fractions by 
centrifugation at 100000 x g for 1 h. The membrane pellet was 
washed once with the same buffer. For immunoblot analysis, 
each preparation was boiled for 3 min in Laemmli sample buf- 
fer [la]. 
2.4. Purification of DGK 
80 kDa DGK was purified from pig thymus cytosolic fraction 
by the same method as described for pig brain [6,7]. The 
purified enzyme was more than 90% pure judging from scan- 
ning densitometry of SDS-polyacrylamide gels that had been 
stained with Coomassie brilliant blue. 
2.5. Quantitation of 80 kDa DGK by immunoblotting 
Immunoblotting was carried out as in [9]. Briefly, cell pro- 
teins were separated by SDS-polyacrylamide gel electrophoresis 
[16], followed by electrophoretic transfer (in a Bio-Rad ap- 
paratus) to a nitrocellulose membrane (0.45 pm, Schleicher and 
Schuell, FRG). The membrane was treated with anti-80 kDa 
DGK immunoglobulin G (50pg/ml) for 2 h, and then in- 
cubated with i2’I-protein A (0.5 pg, 14-20 pCi/ZO ml, ICN) for 
1 h. After extensive washing, the immunoreactive bands were 
detected by autoradiography (Fuji X-ray film) at -80°C. 
Quantitation of 80 kDa DGK was performed by means of den- 
sitometric tracing of the radioactive bands in a densitometer 
(Asuka model 02-802, Japan). At least two different amounts 
of purified 80 kDa DGK (20-70 ng) and crude cell homogenate 
Fig.1 shows the results of immunoquantitation 
of purified pig thymus 80 kDa DGK in the 
presence and absence of crude pig thymus cytosol. 
The immunoreactive signal determined by den- 
sitometric tracing of the autoradiograph increased 
linearly as the amount of purified enzyme applied 
was increased. The slope of the calibration curve 
was not significantly altered by the addition of 
crude cytosol, indicating that this method is ap- 
plicable to DGK quantitation in crude 
homogenates. As shown in fig.2, the antibody used 
could recognize 80 kDa DGK not only in pig 
thymus but also in pig and human lymphocytes. 
The cross-reactivity of the antibody with the 
human enzyme was confirmed by the finding that 
DGK activity in the cytosolic fractions from 
human cells could be immunoprecipitated by the 
antibody (fig.3). The antibody precipitated more 
than 90% of the activity from PBL and Jurkat, but 
only limited precipitation (40070) was achieved 
from HL-60, probably because of the presence of 
non-immunoreactive DGK isozyme(s) in the last- 
mentioned cell line. As can be seen in fig.2, the 
80 kDa DGK content was markedly variable 
depending on cell types. In human cells, HL-60 
contained the 80 kDa isozyme to a much lesser ex- 
tent than lymphocytes, and no immunoreactive 
band was detected for PMN even when large 
amounts (up to 250 kg) of homogenate protein 
were applied. 
The results of immunoquantitation of 80 kDa 
DGK in different pig and human cell homog- 
enates, cytosols and membrane fractions are sum- 
marized in fig.4. The most remarkable finding was 
that in all the lymphocyte preparations examined 
the enzyme was highly enriched in the soluble 
(cytosolic) fraction as compared to the membrane 
fraction. Since the cytosolic fraction contained 
50-60% of the total homogenate protein, it can be 
calculated that more than 90% of cellular 80 kDa 
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Fig. 1. Immunoquantitation of 80 kDa diacylglycerol kinase. 
Different amounts (12.5-100 ng protein) of the enzyme 
purified from pig thymus cytosol were analyzed by 
immunoblotting using rabbit antibody and “‘I-protein A. The 
enzyme was quantitated from integrated areas of the 
absorbance determined by densitometric tracing of the 
radioautograph. The quantitation was carried out without (o) 
or with added thymus cytosolic fraction [(v) 5.3, (w) 10.5, (A) 
15.8 cg cytosolic protein]. Inset: autoradiograph of 
immunoblot of the purified enzyme [lanes: (1) 12.5, (2) 25, (3) 
50, (4) 75, (5) 100 ng protein]. 
DGK was soluble in these cells. Although we deter- 
mined the enzyme level in various regions of pig 
brain as reported in [9], only the data obtained 
with the whole brain and pituitary are shown in 
fig.4. Various brain regions contained comparable 
amounts of the enzyme (80- 130 ng/mg 
homogenate protein) except for pituitary and 
pineal glands (both 10 ng/mg). Unlike the case for 
lymphocytes, no marked enrichment of the enzyme 
in the cytosol was observed for all the brain regions 
analyzed. DGK has so far been reported to be 
located in various membrane fractions in addition 
to the cytosolic fraction [5,8,10,11,18-211. It re- 
mains to be ascertained whether the marked 
enrichment of DGK in the cytosol is restricted to 
lymphocytes. 
The 80 kDa isozyme requires phospholipids as 
activators [6,22], and its substrate, diacylglycerol, 
is believed to be generated in the membrane of 
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Fig.2. Immunoblot analysis of 80 kDa diacylglycerol kinase in 
pig and human cell homogenates. Autoradiographs of pig (A) 
and human (B) cell homogenates analyzed by immunoblotting 
are presented. (A) Lanes: (1) thymocytes, (2) T cell-enriched 
splenocytes, (3) B cell-enriched splenocytes, (4) peripheral 
blood lymphocytes. Lanes a and b represent 25 and 5Ocg, 
respectively, of homogenate protein. (B) Lanes: (1) purified 
80 kDa enzyme (20 ng protein) as the standard, (2) peripheral 
blood lymphocytes, (3) Jurkat, (4) HL-60, (5) polymorpho- 
nuclear leukocytes. The amounts of homogenate protein 
analyzed were: (a) 20, (b) 40, (c) 100, (d) 2OOpg. 
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Fig.3. Immunoprecipitation of cytosolic diacylglycerol kinase 
from human cells. The cytosolic fractions from Jurkat (A , 
32 pg protein), HL-60 (m, 74 fig), and peripheral blood 
lymphocytes (PBL, l , 14 pg) were incubated successively with 
rabbit antibody and Pansorbin (Calbiochem, USA). 
lmmunoprecipitates were removed by centrifugation, and the 
enzyme activity remaining in the supernatant was determined. 
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Fig.4. Quantitative estimation of 80 kDa diacylglycerol kinase 
in pig and human cell homogenates, cytosolic fractions and 
membranes. The content of the 80 kDa enzyme was estimated 
by densitometric tracing of autoradiographs after immuno- 
blotting. The values (means + SD) were obtained from 4-13 
experimental determinations. PBL, peripheral blood lympho- 
cytes; PMN, polymorphonuclear leukocytes. 
agonist-stimulated cells. This raises the possibility 
that cytosolic DGK is an inactive (or less active) 
reservoir form. This notion is supported by the 
observation that the translocation of DGK activity 
from the cytosol to the membranes occurs in 
several types of cells [22-241. We have further 
found that phosphorylation of soluble 80 kDa 
DGK by protein kinase C caused its binding to 
phosphatidylserine vesicles [25]. However, it re- 
mains to be clarified whether the 80 kDa enzyme 
or other DGK isozymes are involved in the 
translocation phenomenon. 
The reason why lymphocytes contain such high 
levels of the 80 kDa enzyme, which represents 
more than 0.2% of total soluble protein in the case 
of pig splenic T cells, is not yet known. It is, 
however, likely that this particular DGK species 
plays an important role in immunological reac- 
tions. The considerable variation noted in the en- 
zyme content among different types of 
lymphocytes uggests that 80 kDa DGK is involved 
in (a) function(s) specific to certain types of lym- 
phocytes. The enzyme content in the cytosol of 
HL-60 (56 f 16 ng/mg protein) is only one-tenth 
those determined for Jurkat (660 rt 140 ng/mg) 
and human PBL (580 + 94 ng/mg). As mentioned 
above, the immunoprecipitation experiments ug- 
gest the occurrence in HL-60 cells of non- 
immunoreactive DGK species in addition to the 
80 kDa enzyme. The apparent absence of the im- 
munoreactive nzyme in human PMN is interesting 
in view of the presence of 80 kDa DGK in undif- 
ferentiated HL-60 cells. 
The anti-pig 80 kDa DGK antibody used here 
has previously been shown to exhibit only limited 
cross-reactivity toward DGKs from other animal 
species. In fact, we could confirm that DGKs from 
rat and mouse thymus did not react with the an- 
tibody (not shown). Fortunately, however, the an- 
tibody could recognize human 80 kDa DGK, 
suggesting that the pig and human enzymes possess 
very similar antigenic properties. 
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